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Abstract
Background: Drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB) is increasing worldwide. In some parts of
the world 10% or more of new TB cases are MDR. The Beijing genotype is a distinct genetic lineage of Mycobacterium
tuberculosis, which is distributed worldwide, and has caused large outbreaks of MDR-TB. It has been proposed that certain
lineages of M. tuberculosis, such as the Beijing lineage, may have specific adaptive advantages. We have investigated the
presence and transmission of DR Beijing strains in the Swedish population.
Methodology/Principal Findings: All DR M. tuberculosis complex isolates between 1994 and 2008 were studied. Isolates
that were of Beijing genotype were investigated for specific resistance mutations and phylogenetic markers. Seventy (13%)
of 536 DR strains were of Beijing genotype. The majority of the patients with Beijing strains were foreign born, and their
country of origin reflects the countries where the Beijing genotype is most prevalent. Multidrug-resistance was significantly
more common in Beijing strains than in non-Beijing strains. There was a correlation between the Beijing genotype and
specific resistance mutations in the katG gene, the mabA-inhA-promotor and the rpoB gene. By a combined use of RD
deletions, spoligotyping, IS1547, mutT gene polymorphism and Rv3135 gene analysis the Beijing strains could be divided
into 11 genomic sublineages. Of the patients with Beijing strains 28 (41%) were found in altogether 10 clusters (2–5 per
cluster), as defined by RFLP IS6110, while 52% of the patients with non-Beijing strains were in clusters. By 24 loci MIRU-VNTR
31 (45%) of the patients with Beijing strains were found in altogether 7 clusters (2–11 per cluster). Contact tracing
established possible epidemiological linkage between only two patients with Beijing strains.
Conclusions/Significance: Although extensive outbreaks with non-Beijing TB strains have occurred in Sweden, Beijing
strains have not taken hold, in spite of the proximity to high prevalence countries such as Russia and the Baltic countries.
The Beijing sublineages so far introduced in Sweden may not be adapted to spread in the Scandinavian population.
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Introduction
Drug resistant (DR) and multi-drug resistant (MDR) tuberculosis
(TB) are increasing worldwide. In some parts of the world 10% or
more of new TB cases are MDR (i.e. at least resistant to rifampicin
(RIF) and isoniazid(INH)) [1,2]. In the Baltics and Russia a large
increase in DR-TB has occurred during the last two decades. Several
studies have associated the Beijing genotype of Mycobacterium
tuberculosis with drug resistance [3]. The Beijing genotype is a distinct
genetic lineage [3], which is distributed worldwide, but predominates
in certain geographic areas. Phylogenetically the Beijing lineage,
defined by spoligotyping, shows thes a m ec h a r a c t e r i s t i c sa st h es o
called EastAsia clade [4], as defined by genomic deletion analysis [5].
The highest prevalencehas been detected in parts of Asia [6,7] and in
the former Soviet Union [8], including in prison systems [9].
Both drug susceptible and DR Beijing strains have caused
substantial transmission of disease [3]. Beijing strains have caused
large outbreaks of MDR-TB [10,11], and strains of the W Beijing
genotype caused a large outbreak of MDR-TB in the United
States in the early 1990s [10]. Further on members of the same
family of strains were observed in many other institutional and
nosocomial outbreaks and in ongoing community transmission [7].
The ubiquity of Beijing strains and an association with
multidrug-resistance [12] has lead to concern that they possess a
unique ability to acquire drug resistance. Such associations have
been found in e.g. Vietnam, Germany, Cuba, the US, Russia and
Estonia [1,3]. However, the endemic Beijing strains in China and
Mongolia are pan-susceptible [3]. In Estonia genetically closely
related Beijing strains showed a range from full susceptibility to
four-drug resistance, indicating that drug resistance had developed
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[13].
Sweden has 9 million inhabitants, of which about 10% are
foreign born. The TB incidence is low, with an incidence of 6.0
per 100,000 population in 2008, and more than two thirds of new
TB cases being foreign born. Drug resistance has increased during
the last five years. In 2008 drug resistance was observed in 13.1%
of all culture confirmed cases, and multidrug-resistance in 3.2%.
We have previously reported the spread of resistant TB in
Sweden [14]. Of 400 isolates, collected during 1994–2005, 48
(12%) isolates were of the Beijing family. We here describe the
Beijing strains in more detail, extending the study to 2008. Our
aim was to investigate the prevalence and possible transmission of
Beijing TB strains in Sweden in relation to drug resistance.
Methods
Ethics Statement
At the Swedish Institute for Infectious Disease Control (SMI),
M. tuberculosis strains are routinely collected for disease surveil-
lance. The current study describes a bacterial collection and
bacterial genotypes could only be combined with the sex, age, and
country of birth for the patients from which the strains were
isolated. Ethical approval was therefore not required. For the same
reason, consent was not obtained from the patients to analyze the
bacterial samples for this population based retrospective study.
Patients and isolates
During the years 1994–2008, all patients in Sweden with drug
resistant TB were reported to SMI. An investigation of contacts
was routinely conducted by the attending physician and reported
to the County Departments of Communicable Disease Control
and Prevention. Patients infected with organisms with identical
RFLP patterns were studied further by a more intensive review
and contact tracing to identify possible epi-links. For this study,
information on epi-links obtained by conventional contact tracing
was retrospectively collected by the Department of Epidemiology
at SMI.
DR M. tuberculosis isolates were obtained from all Swedish TB
laboratories, situated in Gothenburg, Linko ¨ping, Malmo ¨/Lund,
Stockholm and Umea ˚. The isolates and patients from 1994–2005
have been previously described [14]. Isolates resistant to at least
one of the drugs, INH, RIF, ethambutol (EB) or streptomycin
(SM) were included. In Sweden, all isolates are tested for
susceptibility to the first-line drugs INH, EB and RIF. During
the major part of the study all isolates were also tested for
susceptibility to SM, except for the years 2004–2008, when two
laboratories stopped routine testing for SM-resistance. The isolates
were typed and drug susceptibility testing was performed with
standard methods. All laboratories had taken part in the external
quality assurance program for drug susceptibility testing of
M. tuberculosis offered by the Swedish TB reference laboratory at
SMI. The first isolate from each patient identified as resistant to
one or more of these drugs was included in the study. In one case
two different isolates of different genotype from one patient were
included.
Spoligotyping
All isolates were characterized by spoligotyping, which charac-
terizes the polymorphic direct repeat region of the M. tuberculosis
chromosome [15]. The patterns obtained by spoligotyping were
compared by visual examination and by sorting the results in
BioNumerics software version 5.10 (Applied Maths, Kortrijk,
Belgium). The spoligotypes were also compared with those
contained in the international database SITVIT2, an updated
variant of the previously published SpolDB4 database [16], and
were assigned to the major phylogenetic lineages according to
signatures provided in SITVIT2, which defines 62 genetic lineages/
sublineages of M. tuberculosis complex isolates (http://www.pasteur-
guadeloupe.fr:8081/SITVITDemo). The SITVIT2 database con-
tains to date more than 73.000 spoligopatterns for clinical isolates,
with more than 3.000 spoligotype international types (SITs; a
pattern shared by two or more patient isolates). By spoligotyping
isolates of the Beijing genotype were defined by showing
hybridization to at least three of the spacers between spacers 35
to 43 and showing the absence of hybridization to spacers 1 to 34
[17]. Some Beijing strains lack one or more of the nine signature
spacers, due to asymmetrical insertions of IS6110 [18].
IS6110-RFLP
The isolates were cultured on Lo ¨wenstein-Jensen medium,
DNA was extracted and RFLP typing was performed using the
insertion sequence IS6110 as a probe and PvuII as the restriction
enzyme [7,19]. Visual bands were analyzed using the BioNumerics
software version 5.10 (Applied Maths, Kortrijk, Belgium). Strains
with identical RFLP patterns (100% similarity) and five or more
hybridizing bands, were judged to belong to a cluster. On the basis
of the molecular sizes of the hybridizing fragments and the
number of IS6110 copies of each isolate, fingerprint patterns were
compared by the un-weighted pair-group method of arithmetic
averaging using the Jaccard coefficient. Dendrograms were
constructed to show the degree of relatedness among strains
according to a previously described algorithm [20] and similarity
matrixes were generated to visualize the relatedness between the
banding patterns of all isolates.
IS1547-RFLP
Southern hybridization was done by using the same blots (PvuII
- digested DNA) as for IS6110-RFLP. The IS1547 probe for
hybridization was obtained by amplification using the primers 15F
(59-TGTGTGTGCCGCGAGGTGGG-39), and 15R (59-GCAA-
TAGCTCCTATGGCAAGCGGC-39) [21,22].
Mycobacterial Interspersed Repetitive-Unit-Variable-
Number Tandem-Repeat (MIRU-VNTR) Genotyping
Standardized 24-locus MIRU-VNTR typing [23] was per-
formed using the MIRU-VNTR typing kit (Genoscreen, Lille,
France). The PCR-products were run with 1200 LIZ size standard
(GeneScan, Applied Biosystems) on ABI3131xl sequencers. Sizing
of the PCR-fragments and assignments of MIRU-VNTR alleles
were done with the GeneMapper software version 4.0 (Applied
Biosystems) according to the manufacturers’ instructions.
Genotyping for specific resistance mutations
Analysis of the katG gene. DNA sequencing of the 691-bp
fragment of katG was performed using primers F768 katG (39-
CATGAACGACGTCGAAACAG-59) and R1458 katG (39-
GCTACCACGGAACGACGAC-59).
Analysis of the mabA-inhA-promotor. DNA sequencing of
the 980-bp fragment of the inhA promotor region was performed
using primers inhA-F (59-TCGTAGGGCGTCAATACACCGCA-
39) and inhA-R (59-CGTCCAGCAGTCCTGTCATGTGCGT-
39) as previously described [24].
Analysis of the rpoB gene. In RIF resistant strains a 382-bp
fragment of the rpoB-gene containing the RIF resistance-
determining region (RRDR) [25,26] was sequenced using
primers OPRIF-F (59-CGGTCGGCGAGCTGATCC-39) and
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described [27]. Cycle sequencing was performed using The
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems, Sweden). Sequences were compared to those of the
wild-type genes of strain H37Rv (http://www.ncbi.nlm.nih.gov)
using the BioEdit Sequence Alignment Editor.
RD polymorphism
Genomic deletions RD105, RD142, RD150 and RD181 were
identified by PCR using primer sets as previously described [5]
and the PCR products were analysed by agarose gel electropho-
resis.
Rv3135 gene analysis
Rv3135 gene analysis was performed as previously described
[22,28] using primers: Rv3135-F (5’-TCGACTGCCATA-
CAACCTG-3’) and Rv3135-R (5’-GTGCTGGTCGAGAACT-
GAATG-3’) located 210 bp upstream from the Rv3135 start site
and 23 bp downstream from the stop codon, respectively. These
primers amplify a 632-bp product from strain H37Rv.
mutT gene polymorphism
Mutation analysis of mutT2 and mutT4 was performed by
nucleotide sequencing of these genes. Amplification was carried
out using primers [29] generating fragments of ,800 and
,1000 bp that were visualized on a 1% agarose gel. PCR
products were purified using spin columns (GE Healthcare). The
mutations GGA to CGA (Gly to Arg) at codon position 58 for
mutT2 and CGG to GGG (Arg to Gly) at codon position 48 for
mutT4 was detected using the ABI Big Dye v. 3.1 cycle sequencing
kit.
Subgrouping of Beijing strains – genomic sublineages
Based on the results of RD deletion analysis, spoligotyping,
IS1547, mutT gene polymorphism and Rv3135 gene analysis the
70 Beijing strains were allocated to genomic sublineages, where
each sublineage represented a unique genetic setup according to
these analyses.
Review of patient data
Available demographic data were collected for all patients
infected with Beijing strains, such as age, gender and country of
origin.
Statistical associations were generated by MINITAB Version 15
using x
2 (Chi-square) test. For analysis of epidemiological trends
over time the Sas ARIMA Model was used.
Results
Patients
Altogether 536 DR isolates from 535 patients were collected in
1994–2008. Sixty-nine (13%) of the 535 patients with DR-TB
were found to have strains of Beijing genotype as defined by
spoligotyping.
In one case multiple strains were found in the same patient. The
patient, born in 1970, had in May 2003 a sputum sample from
which three different isolates were cultured, one of which was of
Beijing genotype and resistant to INH. In December 2003 the
same patient presented with a sample containing yet another
Beijing strain with a different RFLP pattern. The second isolate
was resistant to all four drugs. This patient came from Azerbaijan,
and was reported to have been in prison.
A median of four patients with DR Beijing strains per year was
observed, with a slight trend of increase over the years (p=0.0175,
significance level of 5%) following the overall increase in DR
isolates (p=0.0421, significance level of 5%) during those years
(Fig. 1). Of the 69 patients with DR Beijing strains 6 (8.7%) were
born in Sweden and 63 born abroad. Of the 466 patients with DR
non-Beijing strains 63 (13.5%) were born in Sweden and 403 born
abroad. Forty-two (67%) of the 63 foreign born TB-patients
infected with DR Beijing strains were women and 27 were men
(Table 1). The majority of the patients with DR Beijing strains
(58%) were in the age group of 25–44 and 20% in the age group
15–24 (Table 1), which is consistent with the age distribution for
patients with DR-TB in general (Table 1) in Sweden. Patients with
Beijing strains were more often women than were those infected
with strains of other genotypes (p-value=0.0268, using a one-
sided test of hypothesis at 5% significance level).
Figure 1. Number of patients with DR strains (Beijing and non Beijing) isolated over time. A trend of increase over the years (p=0.0175,
significance level of 5%) was observed for DR Beijing isolates as well as for all DR isolates (p=0.0421, significance level of 5%), using the Sas ARIMA
Model for analysis of epidemiological trends over time.
doi:10.1371/journal.pone.0010893.g001
The Beijing Genotype in Sweden
PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10893Country of origin
Of the 69 patients with DR Beijing strains that were foreign
born a large proportion came from Asia (75%); the majority of
these patients were from Vietnam (n=19) and Thailand (n=7),
which are the two single countries that contributed with most
patients with Beijing strains (Supporting material Table S1). Most
of the patients from Asia with DR-TB were found to have strains
of Beijing genotype. Thus, 59% of patients from Vietnam, 54% of
patients from Thailand and all (altogether n=17) patients with
DR-TB from Armenia, Azerbaijan, Bhutan, Cambodia, China,
Kazakhstan, Korea, North Korea and Uzbekistan had strains of
Beijing genotype. Only 11 (4%) of 280 patients from Africa with
DR-TB had Beijing strains.
Of the six Swedish born patients that were infected with DR
Beijing strains three had parents who were born outside Sweden
(Tibet, Hungary and Chile). The Swedish born patient with parents
with origin in Tibet, probably was infected while visiting Tibet.
Strains
Of the 70 strains that were defined by spoligotyping to be of the
Beijing genotype 66 had all the characteristic spacers 35–43,
corresponding to the shared type SIT1 as defined in SITVIT2,
and four isolates lacked spacer 37, corresponding to SIT265
(Table 2). By RFLP the isolates had 13 to 23 IS6110 insertions.
Drug resistance
Of the 70 Beijing strains 51 were INH resistant, 18 were
resistant to RIF, and 17 were MDR. One strain was defined as
extensively drug resistant (XDR), in this case resistant to amikacin
and ofloxacin. Thirty-three strains were monoresistant, either to
SM (n=17), to INH (n=14), to RIF (n=1) or to EB (n=1). While
17 (24%) of the Beijing strains were MDR, only 59 (13%) of 466
DR non-Beijing strains were MDR during the same period, which
is a statistically significant difference [p-value 0.0134, 95%
CI=(0.0137; 0.2258)].
Genotyping for specific resistance mutations
Resistance mutations in the katG gene and/or in the inhA
promoter region were found in 49/51 (96%) of the Beijing strains
with phenotypic INH resistance (Table 3). Forty-four isolates
(86%) had a mutation in katG, showing a nucleotide exchange in
katG codon 315 from AGC to ACC. Eight isolates (16%) had a
mutation in the inhA promoter region showing an exchange from
C to T at position -15. Three of the strains (including the XDR
strain) had both mutations. All 17 MDR strains had the 315ACC
mutation in the katG gene. Resistance mutations in the RIF
resistance-determining region of the rpoB gene were found in 16 of
18 strains with phenotypic RIF resistance. Mutation in rpoB codon
531 was most common (n=13).
Table 1. Age and sex of 535 patients with drug resistant
strains, and relative proportion of patients with Beijing strains.
Male Female
Age (years) total Beijing % total Beijing %
0–14 14 0 0 16 1 6.3
15–24 50 4 8 63 10 15.9
25–44 143 16 11.2 136 24 17.6
45–64 48 7 14.6 32 4 12.5
65+ 12 0 0 21 3 14.3
Total* 267 27 10.1 268 42 15.7
*Patients with Beijing strains were more often women than were those infected
with strains of other genotypes (p-value=0.0268, using a one-sided test of
hypothesis at 5% significance level).
doi:10.1371/journal.pone.0010893.t001
Table 2. Polymorphims of M. tuberculosis strains of Beijing genotype.
Region of difference (RD)
a Mutation in mutT genes
b
Genomic sublineage
Number of
isolates (n=70) SIT
c 105 181 150 142 Rv3135
d mutT2 mutT4 IS1547
e
11 2 6 5 +++ + 0.15 kb 228
21 3 1 22++at 2 + 5
31 1 22++at 2 + 6
41 1 22++at 2 + 7
54 1 1 22++t ++1
63 1 22++t ++2
71 1 22++t ++3
83 2 6 5 22++t ++1
91 1 2 2 + 2 t ++1
10 4 1 222 + t ++1
11 1 1 222 + t ++4
Isolates are grouped into 11 arbitrary sublineages on the basis of the polymorphisms relative to genomic deletion RD105, RD181, RD150 and RD142, RV3135 IS1547
RFLP pattern and mutations in genes mutT4 and mutT2.
apresence (+) or absence (2) of the specific genomic region.
bpresence (+) or absence (2) of the specific mutation.
cspoligotype international type.
dsublineage 1: a 0.15-kb PCR product, sublineage 2–4: ‘‘atypical’’ isolates, with a 1.97-kb PCR product, sublineage 5–11: ‘‘typical’’ isolates, with a 1.02-kb PCR product.
epattern 1: three bands (1.7, 2.1, and 2.5 kb), pattern 2: two bands (2.1 and 2.5 kb), pattern 3–7: individual patterns, all containing the 2.5 kb band, except pattern 8 that
has no 2.5 kb band.
doi:10.1371/journal.pone.0010893.t002
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The isolates were analysed for the four deletions RD105,
RD181, RD150, and RD142 [5]. The majority (n=69) of the
strains had the RD105 and RD181 deletions. One strain had in
addition to those two deletions also the RD142 deletion, and five
strains had the two deletions plus the RD150 deletion. One strain
(BTB04-003) had all RD intact, including RD105.
IS1547 polymorphism
Eight different patterns were seen. All strains except one
(BTB04-003) had a band of 2.5 kb. This band has been reported
to be common to all Beijing strains [22]. A single IS1547-RFLP
band (2.5 kb) pattern was observed for 13 strains, corresponding
to the pattern of ‘‘atypical’’ strains described by Mokrousov et al
[22] while a three band (1.7, 2.1, and 2.5 kb) pattern was found
for 49 strains, corresponding to the pattern of ‘‘typical’’ Beijing
strains [22]. Three strains had a two band (2.1 and 2.5 kb)
pattern, while five strains had individual patterns, all containing
the 2.5 kb band.
Rv3135 gene analysis
PCR of the Rv3135 genome region showed a 1.02-kb fragment
in 54 strains, and a 1.97-kb fragment in 15 strains. One strain
(BTB04-003) had a PCR fragment of around 0.15-kb.
mutT gene polymorphism
All except one strain (n=69) had the mutT4 mutation, and 53
isolates had the mutT2 mutation.
Genomic sublineages
By a combined use of RD deletions, spoligotyping, IS1547, mutT
gene polymorphism and Rv3135 gene analysis the 70 Beijing
strains could be divided into 11 arbitrarily numbered genomic
sublineages (Table 2). Fifty-four strains (7 sublineages) fulfilled the
criteria of being ‘‘modern’’, or ‘‘typical’’ Beijing isolates according
to Rv3135 gene analysis [22]. Of the 16 more ‘‘ancient’’ or
‘‘atypical’’ Beijing strains 7 strains clustered in 3 different IS6110
RFLP clusters, while 21 of the 54 ‘‘modern’’ strains clustered in 7
different RFLP clusters.
One strain (BTB04-003) lacked all the properties of a modern
Beijing strain, except for its SIT265 spoligotype. It had all RD
intact, had wildtype mutT2 and mutT genes, and did not have the
IS1547 2.5 kb band, which is regarded as specific for Beijing
strains [22]. It even lacked the RD105 deletion which is
considered to be a marker for Beijing strains.
Epidemiological links
In this study 28 (41%) of the 69 patients with Beijing strains
were found in altogether 10 clusters (2–5 per cluster) as defined
by IS6110 RFLP, yielding 51 different patterns (Fig. 2) while 240
patients (52%) of 466 patients with non-Beijing DR-TB strains
during the same time period were in clusters. In three clusters the
patients with Beijing strains were from the same country of origin:
two, two and four patients respectively from Vietnam. The largest
cluster (SMI 009) comprised five patients. Four of the patients in
this cluster were from the former Soviet Union, three of them
having MDR strains. The fifth patient in this cluster came from
Somalia. All strains that clustered by IS6110-RFLP were identical
also by RD deletions, spoligotyping, IS1547, mutT gene
polymorphism and Rv3135 gene analysis. Of the six Swedish
born patients two were in clusters, one with two patients from
Vietnam, and one with a patient from Bhutan. Contact tracing
established possible epidemiological linkage for one of the clusters
(cluster SMI 176). This was the cluster comprising the two
patients from Sweden and Bhutan. The two men had shared the
same indoor recreational activity during the wintertime of 2002.
In the other clusters no epidemiological link was found by
conventional contact tracing.
By MIRU-VNTR 31 (45%) of the 69 patients with Beijing
strains were found in altogether 7 clusters (2–11 per cluster),
yielding 45 different patterns (Fig. 2). Thus the MIRU-VNTR
typing, with fewer and larger clusters, was less discriminatory than
IS6110 RFLP. The two strains where a possible epidemio-
logical linkage was established differed in one allele and thus
did not cluster in MIRU-VNTR. All strains that clustered by
MIRU-VNTR were identical also by RD deletions, mutT gene
polymorphism and Rv3135 gene analysis, but not by spoligotyping
and IS1547.
Four of the IS6110 RFLP clusters contained isolates that
differed by MIRU-VNTR (Fig. 2). The combination of MIRU-
VNTR with RFLP resulted in the disappearance of two clusters,
and a reduction of the number of isolates in two clusters,
compared to the clustering observed with IS6110 RFLP clustering
alone.
Discussion
In this study we found that patients with DR Beijing strains have
been diagnosed for more than a decade in Sweden. The majority
of the patients were foreign born, and their country of origin
reflects areas where the Beijing genotype is prevalent.
The Beijing genotype has been reported to be most prevalent in
Asia [3,7,30] and parts of the former Soviet Union [3]. In this
study patients with DR Beijing strains were mainly from Asia
(75%); the majority of patients from Asia being from Vietnam and
Thailand. This is in accordance with the reports of Beijing strains
predominating in China and neighbouring Asian countries such as
Thailand [7] and Vietnam [31]. In Vietnam the proportion of
Beijing strains was reported to be 54% [31], and in Thailand 44%
[32].
Table 3. Resistance related mutations in Beijing strains.
MDR isolates n=17 katG inhA rpoB
n=10 Ser315Thr wild-type Ser531Leu
n=2 Ser315Thr wild-type wild-type
n=2 Ser315Thr C(-15)T Ser531Leu
n=1 Ser315Thr
Ile335Val
wild-type Ser531Leu
n=1 Ser315Thr wild-type Asp516Val
n=1 Ser315Thr wild-type Asp516Tyr
INH monoresistant
isolates n=34 katG inhA rpoB
n=26 Ser315Thr wild-type ND
n=5 wild-type C(-15)T ND
n=2 wild-type wild-type ND
n=1 Ser315Thr C(-15)T ND
RIF monoresistant
isolates n=1 katG inhA rpoB
n=1 wild-type wild-type Leu533Pro
All strains (n=52) harbored the mutation Arg463Leu. ND: not done.
doi:10.1371/journal.pone.0010893.t003
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relatedness among strains according to [20] and similarity matrixes were generated to visualize the relatedness between the banding patterns of all
isolates. MIRU-VNTR = Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat. The genomic sublineages were arbitrarily
defined on the basis of the combined use of RD deletions, spoligotyping, IS1547, mutT gene polymorphism and Rv3135 gene analysis (Table 2).
SM=streptomycin, INH=isoniazid, RIF=rifampicin, EB=ethambutol, R=resistant, S=susceptible.
doi:10.1371/journal.pone.0010893.g002
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former Soviet Union, reflecting the fact that only a few TB patients
originating from the former Soviet Union were reported in
Sweden during this period [33]. Yet, all DR isolates from patients
from Kazakhstan and Azerbaijan were of Beijing genotype, which
conforms to the high prevalence of the Beijing genotype reported
in the former Soviet Union [1,13,34,35].
Beijing strains are however still uncommon in Africa, except for
South Africa [36]. Only 11 (16%) of the patients with DR Beijing
strains were from Africa, although as much as 52% of 535 patients
with DR-TB in Sweden were of African origin. Thus, the
prevalence of the Beijing genotype in Sweden appears to reflect
the prevalence of the Beijing genotype in the country of origin of
the patients as well as the proportion of TB patients from these
countries.
Age and sex
Patients with Beijing strains were significantly more often
women than were those infected with strains of other genotypes. In
only one study such gender difference has been previously
recorded [37]. The higher number of female patients with Beijing
strains might reflect the larger immigration of women than of men
from some countries with a high prevalence of Beijing strains.
Thus there were more women than men from Thailand and
Vietnam, also among those with non-Beijing strains.
Simultaneous infections
One patient harboured at least four different strains, of which two
were of Beijing genotype. The patient came from a high endemic
area where Beijing strains are circulating. This confirms previous
findings reporting mixed infections [35,38,39,40,41,42,43,44]. Inter-
estingly, most mixed infections reported involved Beijing strains,
sometimes in combination with non-Beijing strains, and the patients
came from areas where they had been heavily exposed to TB.
Strains of Beijing genotype more often MDR
In this study the prevalence of multidrug-resistance was
significantly higher in Beijing strains than in DR non-Beijing
strains, which is in accordance with multiple reports of an
association between the Beijing genotype and drug resistance and
multi-drug resistance [13,45,46] Thus, in Central Asia and the
former Soviet Union the Beijing genotype is associated with drug
and multidrug-resistance [12,45], which is reflected in a high
prevalence of DR Beijing strains in patients from these countries.
In this study there was only one isolate with mono-resistance to
RIF, which is in agreement with previously published data [47],
indicating that the ability to acquire INH resistance is the first and
most important step to acquire MDR TB in most instances [48].
Drug resistance genotypes
Several studies indicate an association between Beijing genotype
and mutations in the katG gene [3,49,50]. The majority of the 51
strains with INH resistance had the katG 315 substitution, while
five isolates had the -15 inhA mutation in the promoter of the inhA
gene, which encodes an enoyl acyl carrier protein reductase
involved in fatty acid synthesis [51]. In Northwestern Russia all
Beijing isolates from new cases that were INH resistant had the
katG 315 substitution [49]. In a study from Kazakhstan [43] all
MDR strains, irrespective of genotype, carried the mutation at
codon 315 of the katG gene, and in a group of INH resistant but
RIF sensitive strains, this mutation was significantly more
prevalent in the Beijing than in the non-Beijing group of strains
[43]. The katG 315 mutation was more common among Beijing vs.
non-Beijing strains in a study from Russia (96.8% vs. 85.7%) [52]
and Korea (65% vs. 50%)[46], while the -15 inhA mutation was
less common among Beijing strains (14% vs. 25% for non-Beijing
strains) [46].
However, in a study of children with DR TB in South Africa,
the -15 inhA promoter region mutation was the most frequent
mutation (59%) in INH resistant Beijing strains [47]. One reason
for the predominance of this mutation in the study from South
Africa could be that it was exclusively detected in the Beijing 220
subgroup, a well-recognized DR strain in the Western Cape
Province [47], indicating a clonal dissemination of this DR
strain. Interestingly, in our study four of the five Beijing strains
with the -15 inhA promoter region mutation occurred in patients
from Africa, and seven of the eleven patients from Africa (Somalia,
Ethiopia and Rwanda) with INH resistant strains had the katG 315
substitution.
Most of the RIF resistant Beijing strains had a mutation at the
531 codon of rpoB. This is in accordance with a previously
reported strong association between Beijing strains with multidrug-
resistance and mutations at codon 531 [12,50,53]. Thus the rpoB
531 mutation was more prevalent in MDR Beijing than non-
Beijing strains from Russia [52] (77.3% vs. 28%) and Kazakhstan
(71.2 vs. 46.2%) [43]. On the other hand a study from Korea
showed lower rates of the rpoB 531 mutation in Beijing vs. non-
Beijing MDR-TB strains (41 vs. 66%) [46].
Interestingly the only RIF mono-resistant strain (isolate BTB06-
182, sublineage 2) from a patient originating from Thailand
carried a rare mutation at the 533 codon of the rpoB gene.
Resistance to RIF in most cases occurs in combination with INH
resistance, and in the few available reports of RIF mono-resistance
the mutations underlying the resistance are rarely observed in
MDR strains. An unusual duplication at codon 415 was observed
in a mono-resistant strain spreading in an HIV-seropositive
population [54]. In a study from Thailand, the prevalence of the
common mutations in codon 531 was lower in RIF monoresistant
strains than in MDR strains [55].
Association between genotype and specific resistance
mutations
From all these studies, there appears to be a correlation between
the Beijing genotype and specific resistance mutations. Few studies
have reported on correlations between other genotypes and
mutations in resistance genes [56]. In a study from Russia, there
appeared to be a correlation between the genotype and specific
mutations conferring resistance to RIF [57]. Another study of
MDR M. tuberculosis isolates from India [53]only showed an
association between rpoB 531 mutations and Beijing genotype,
while the type of mutations in the rpoB gene were independent of
genotype (spoligopattern) in non-Beijing strains.
Genomic lineages and adaptive advantage
This collection of Beijing strains from various parts of the world
illustrates the genomic diversity of the Beijing family. Based on a
number of genetic markers the 70 Beijing isolates could be
allocated into 11 different arbitrary sublineages, from more
‘‘modern’’, or ‘‘typical’’ [22] to more ‘‘ancient’’ or ‘‘atypical’’
[22] variants.
The particular nature of strain BTB04-003, isolated from a man
from Bangladesh, which lacked all the properties of a modern
Beijing strain, except for its SIT265 spoligotype, remains to be
elucidated. The lack of deletion of RD105, which is considered to
be a marker for Beijing strains [5,58], has been reported in one
other strain [59]. This strain was assigned to the spoligotype
SIT269, which is defined as ‘‘Beijing-like’’ in SITVIT2. The
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strains with non-Beijing spoligoprofiles [60]. The BTB04-003
strain may be either a very early ancestral variant, occurring
before the RD105 deletion, or may have developed independently
through selective pressure.
Epidemiological links
Contact tracing revealed a possible connection between only two
of the patients in the ten IS6110 RFLP clusters. In this cluster the
strains were not identical by MIRU-VNTR. The discordance
observed between IS6110 RFLP and MIRU-VNTR is in agreement
with a study of Beijing strains in South Africa [61], where molecular
epidemiological linking of cases varied significantly depending on the
genotyping method used. Isolates with the same fingerprinting
pattern are usually thought to reflect ongoing transmission. However,
Beijing strains exhibit restricted variation in RFLP patterns. It was
recently shown [62] that two Beijing strains exhibiting the same
fingerprinting pattern harbored substantial genomic diversity. The
fact that strains with identical genotyping patterns can accumulate
significant amounts of genetic diversity indicates that epidemiological
links between strains with identical genotyping data can be more
remote and are likely to represent older transmission events rather
than cases of recent transmission among patients in one RFLP
cluster[62]. In this study four of the 10 RFLP clusters could be further
resolved on the basis of MIRU-VNTR data, resulting in the
disappearance of two clusters, and the reduction of the number of
strains in two clusters. Two more clusters had strains with different
drug resistance genotypes. Thus the clustering by conventional
IS6110 RFLP in this study in mostcases probably reflects the fact that
the patients in the individual cluster came from the same
geographical area, and had strains of genotypes that were prevalent
in their respective countries of origin.
Little spread of the Beijing family in Scandinavian
countries
The global distribution of Beijing strains and their ability to
predominate suggests that they have advantages to other strains
that make them better adapted to infect and cause disease
in humans. It has been proposed that certain lineages of
M. tuberculosis, such as the Beijing lineage, may have specific
adaptive advantages [4,63,64]. Active transmission of Beijing
strains has been described in the US [65], Estonia [13] and the
Canary Islands [66]. There is a recent and rapid emergence of
Beijing strains in Cape Town, SA [67], and a recently evolved
sublineage of the Beijing family has been associated with an
increased ability to spread and cause disease in South Africa [58].
Yet, in spite of the closeness to Russia and the Baltic states Beijing
strains have not been observed to spread extensively within any of
the Scandinavian countries. In Finland, that is most closely
geographically situated to both Russia and Estonia, only 1% of
patients were infected with a Beijing strain in 2001 [68]. In
Denmark 1% of Danish born and 3.6% of immigrant TB patients
had Beijing strains [69]. No evidence of an increase in Beijing
strains was found over time, and very little transmission from
immigrants to the indigenous populations was observed. In this
population based study, in spite of a steady influx of Beijing strains,
no, or very little spread of Beijing strains within Sweden could be
documented.
The incidence of Beijing strains is low in most Western
European countries, although strains of the Beijing genotype
represent an increasing cause of MDR-TB in Germany [41]. The
low incidence of Beijing strains in the Scandinavian countries may
indicate that there are efficient national TB control programs. On
the other hand, large outbreaks with other, non-Beijing, strains
have been reported among immigrants in Sweden [13], Norway
[70] and Denmark [71]. Thus an INH resistant non-Beijing
M. tuberculosis strain caused an outbreak in Sweden, now involving
more than 100 patients, mainly immigrants from the Horn of
Africa [33], and another INH resistant clone caused an outbreak
in East African patients in Norway [70]. In both cases eventually
MDR variants emerged, also in the native population [14,70].
It has been suggested that M. tuberculosis complex lineages are
adapted to particular human populations [4,64,72,73], and that
lineages that are rare in a specific human population are not adapted
to transmit and cause secondary cases in this specific population [4].
InSanFrancisco,patientsinfectedwithisolatesoftheEuro-American
lineage (as defined by lineage specific DNA polymorphisms [4]) were
three times more likely to generate a secondary case than patients
infected with any other strain, while the East-Asian (Beijing) lineage
had the lowest secondary case-rate ratio [4]. It is assumed that the
modern Beijing strains have a higher degree of transmissibility than
older, atypical variants. The spread of a modern Beijing sublineage
that has a high transmissibility is currently increasing in Japan, while
the spread of an ancient sublineage has decreased [74]. In South
Africa a recently evolved sublineage of the Beijing strain family was
associated with an increased ability to spread and causedisease[58]. It
is possible that the Beijing sublineages introduced in Sweden so far
are not adapted to spread in the Scandinavian or immigrant
populations.
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